Skip to main content

CORRECTION article

Front. Cardiovasc. Med., 20 July 2022
Sec. Coronary Artery Disease
Volume 9 - 2022 | https://doi.org/10.3389/fcvm.2022.987880

Corrigendum: Pre-existing proton pump inhibitor treatment and short-term prognosis of acute myocardial infarction patients

This article is a correction to:

  1. Pre-existing Proton Pump Inhibitor Treatment and Short-Term Prognosis of Acute Myocardial Infarction Patients

    1. Read original article
\nJuntao Xie,Juntao Xie1,2Qingui ChenQingui Chen3Dejian He, Dejian He4,5*
  • 1Intensive Care Unit, The First People's Hospital of Chenzhou, Chenzhou, China
  • 2Intensive Care Unit, The Chenzhou Affiliated Hospital, Hengyang Medical School, University of South China, Chenzhou, China
  • 3Department of Medical Intensive Care Unit, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
  • 4Department of Emergency, The First People's Hospital of Chenzhou, Chenzhou, China
  • 5Department of Emergency, The Chenzhou Affiliated Hospital, Hengyang Medical School, University of South China, Chenzhou, China

A corrigendum on
Pre-existing Proton Pump Inhibitor Treatment and Short-Term Prognosis of Acute Myocardial Infarction Patients

by Xie, J., Chen, Q., and He, D. (2022). Front. Cardiovasc. Med. 9:919716. doi: 10.3389/fcvm.2022.919716

In the published article, there was an error regarding the affiliation for Juntao Xie and Dejian He. As well as having the affiliation “The Chenzhou Affiliated Hospital, Hengyang Medical School, University of South China,” they should also have “The First People's Hospital of Chenzhou.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: myocardial infarction, proton pump inhibitors, histamine 2 receptor antagonists, risk factors, prognosis

Citation: Xie J, Chen Q and He D (2022) Corrigendum: Pre-existing proton pump inhibitor treatment and short-term prognosis of acute myocardial infarction patients. Front. Cardiovasc. Med. 9:987880. doi: 10.3389/fcvm.2022.987880

Received: 06 July 2022; Accepted: 07 July 2022;
Published: 20 July 2022.

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Xie, Chen and He. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Dejian He, 375965482@qq.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.